Article Figures & Data
Figures
- Figure 1.
Results for the Primary Outcome and Major Vascular Events in SHARP
Eze/simv=ezetimibe 10 mg plus simvastatin 20 mg daily.
Reproduced from Baigent C et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011;377(9784):2181–2192. With permission from Elsevier.
- Figure 2.
Renal Outcomes in the SHARP Study
Eze/simv=ezetimibe 10 mg plus simvastatin 20 mg daily.
Reproduced from Baigent C et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011;377(9784):2181–2192. With permission from Elsevier.
Tools
Table of contents
Cited By...
- No citing articles found.